327 results on '"Moccia, Marcello"'
Search Results
2. Integration of the expanded disability status scale with ambulation, visual and cognitive tests
3. Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project
4. The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis
5. Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications
6. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis
7. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
8. Being highly sensitive person negatively impacts on cognitive and psychosocial fatigue in multiple sclerosis patients: A cross-sectional, monocenter study
9. Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
10. Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosis
11. Tango classes in people with Multiple Sclerosis (PwMS): Impact on motor and non-motor functions
12. Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis
13. Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study
14. Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy
15. Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience
16. Exploring the relation between reserve and fatigue in multiple sclerosis
17. Epidemiology of multiple sclerosis in the Campania Region (Italy): Derivation and validation of an algorithm to calculate the 2015-2020 incidence
18. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
19. Multiple sclerosis progression: time for a new mechanism-driven framework
20. Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study
21. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
22. Technological interventions in European dementia care: a systematic review of acceptance and attitudes among people living with dementia, caregivers, and healthcare workers.
23. Dysphagia assessment in patients with multiple sclerosis – an additional piece to disability burden.
24. Disability assessment using Google Maps
25. Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19
26. Radiological Reporting Systems in Multiple Sclerosis.
27. Generalised boundary shift integral for longitudinal assessment of spinal cord atrophy
28. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study
29. Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study
30. 2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis
31. Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study
32. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
33. B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple Sclerosis
34. Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin
35. Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study.
36. Notch3 protein expression in skin fibroblasts from CADASIL patients
37. A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing‐remitting multiple sclerosis
38. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment
39. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis
40. Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)
41. Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a
42. CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients
43. Molecular and Metabolic Imaging in Multiple Sclerosis
44. Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study
45. Neurology and the Internet: a review
46. A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study
47. Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis
48. The Dress: Transforming a web viral event into a scientific survey
49. Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease
50. Neurofilament in clinical practice: Is the multiple sclerosis community ready?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.